Effects of renin-angiotensin system blockade on islet function in diabetic rats

Journal of Endocrinological Investigation

Volumn 33, Issue 1, 2010, Pages 13-19

  Yuan, L ^a   Li, X ^b   Xui, G L ^a   Qi, C J ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetes mellitus; Fibrosis; Islet function; Oxidative stress; Reninangiotensin system

Indexed keywords

ANGIOTENSINOGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; PERINDOPRIL; TRANSFORMING GROWTH FACTOR BETA1; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE MODEL; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; LIPID DIET; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

EID: 77950535437     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346544     Document Type: Article

References (18)

1. Andraws R, Brown DL. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol 2007, 99: 1006-1012
2. Hansson L, Lindholm LH, Niskanen L, et al. Effect of angiotensin- converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril prevention project (CAPPP) randomized trial. Lancet 1999, 353:611-616
3. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduced in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359: 995-1003.
4. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Parti. A meta-analysis of randomized clinical trials. Diabetes Matab, 2004, 30: 487-496
5. Tahmasebi M, Puddefoot JR, Inwang ER, Vinson GP. The tissue renin-angiotensin system in human pancreas. J Endocrinol 1999, 161: 317-322
6. Huang Z, Jansson L, Sjöholm A. Pancreatic islet blood flow is selective enhanced by Captopril, irbesartan and pravastatin, and suppressed by palmitate. Biochem Biophys Res Commun 2006, 346: 26-32.
7. Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vase Biol 1999, 19: 1623-1629
8. McDaniel ML, Kwon G, Hill JR, Marshall CA, Corbett JA Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med, 1996, 211: 24-32.
9. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004, 53: 989-97.
10. Kato Y, Miura Y, Yamamoto N, Ozaki N, Oiso Y. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction. Diabetologie 2003, 46: 1228-1233
11. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensin-Converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005, 46: 821-826
12. Cooper ME, Tikellis C, Thomas MC. Preventing diabetes in patients with hypertension: one more reason to block the renin-angiotensin system. J Hypertens Suppl 2006, 24: S57-63.
13. Eprosartan dual action offers clinical benefit for elderly and over-weight hypertensives. Cardiovasc J S Afr 2004, 15: 91-92
14. Rincon-Choles H, Kasinath BS, Gorin Y, Abboud HE. Angitensin Il and growth factors in the pathogenesis of diabetic nephropathy. Kidney lnt Suppl 2002, 82: 8-11.
15. Leask A, Holmes A, Abraham DJ. Connective tissue growth factor a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 2002, 4: 136-142
16. Abreu JG, Ketpura NI, Reversade B. Connective tissue growth fator (CTGF) modulates cells signaling by BMP and TGF-beta. Nat Cell Biol 2002, 4: 599-604.
17. Kaneto H, Kawamori D, Matsuoka TA, Kajimoto Y, Yamasaki Y. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther 2005, 12: 529-533
18. Yang C, Chao J, Hsu WH. The effect of bradykinin on secretion of insulin, glucagon, and somatostatin from the perfused rat pancreas. Metabolism 1997, 46: 1113-1115